{"url_path":"/sec/codx/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-024738-index.html","accession_number":"0001493152-26-024738","cik":"0001692415","ticker":"CODX","issuer_name":"Co-Diagnostics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1692415/0001493152-26-024738-index.html","primary_entity_key":"0001692415","primary_entity_name":"Co-Diagnostics, Inc."},"word_count":151,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit\nNo.:**\n \n**Description:**\n\n4.1\n \n[Form of Pre-Funded Warrant](ex4-1.htm)\n\n4.2\n \n[Form of Common Warrant](ex4-2.htm)\n\n10.1*\n \n[Form of Securities Purchase Agreement](ex10-1.htm)\n\n10.2\n \n[Form of Registration Rights Agreement](ex10-2.htm)\n\n10.3\n \n[Form of Placement Agency Agreement](ex10-3.htm)\n\n99.1\n \n[Press Release dated May 19, 2026](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n*Schedules\nand exhibits have been omitted from this exhibit pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish\ncopies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.\n\n \n\n \n\n \n\n \n\n** **\n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, hereunto duly authorized.\n\n \n\n \n**CO-DIAGNOSTICS,\nINC.**\n\n \n \n \n\nDate:\nMay 21, 2026\nBy:\n*/s/\nBrian Brown*\n\n \nName:\nBrian\nBrown\n\n \nTitle:\nChief\nFinancial Officer\n\n \n \n(Principal\nFinancial and Accounting Officer)"}